Literature DB >> 20695019

Mutations in PEX10 are a cause of autosomal recessive ataxia.

Luc Régal1, Merel S Ebberink, Nathalie Goemans, Ronald J A Wanders, Linda De Meirleir, Jacques Jaeken, Maarten Schrooten, Rudy Van Coster, Hans R Waterham.   

Abstract

Peroxisomal biogenesis disorders typically cause severe multisystem disease and early death. We describe a child and an adult of normal intelligence with progressive ataxia, axonal motor neuropathy, and decreased vibration sense. Both patients had marked cerebellar atrophy. Peroxisomal studies revealed a peroxisomal biogenesis disorder. Two mutations in PEX10 were found in the child, c.992G>A (novel) and c.764_765insA, and in the adult, c.2T>C (novel) and c.790C>T. Transfection with wild-type PEX10 corrected the fibroblast phenotype. Bile acid supplements and dietary restriction of phytanic acid were started. Peroxisomal biogenesis disorders should be considered in the differential diagnosis of autosomal recessive ataxia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20695019     DOI: 10.1002/ana.22035

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  31 in total

Review 1.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

2.  Zellweger Spectrum Disorder with Mild Phenotype Caused by PEX2 Gene Mutations.

Authors:  Andrea Mignarri; Claudia Vinciguerra; Antonio Giorgio; Sacha Ferdinandusse; Hans Waterham; Ronald Wanders; Enrico Bertini; Maria Teresa Dotti; Antonio Federico
Journal:  JIMD Rep       Date:  2012-01-29

3.  Clinical utility gene card for: Zellweger syndrome spectrum.

Authors:  Hendrik Rosewich; Hans Waterham; Bwee Tien Poll-The; Andreas Ohlenbusch; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2014-11-19       Impact factor: 4.246

4.  Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: slowly progressive recessive ataxia.

Authors:  Mathilde Renaud; Claire Guissart; Martial Mallaret; Sacha Ferdinandusse; David Cheillan; Nathalie Drouot; Jean Muller; Mireille Claustres; Christine Tranchant; Mathieu Anheim; Michel Koenig
Journal:  J Neurol       Date:  2016-05-26       Impact factor: 4.849

5.  Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.

Authors:  David Cheillan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity.

Authors:  Małgorzata Rydzanicz; Teresa Joanna Stradomska; Elżbieta Jurkiewicz; Ewa Jamroz; Piotr Gasperowicz; Grażyna Kostrzewa; Rafał Płoski; Anna Tylki-Szymańska
Journal:  J Appl Genet       Date:  2017-10-18       Impact factor: 3.240

7.  Novel PEX3 Gene Mutations Resulting in a Moderate Zellweger Spectrum Disorder.

Authors:  C Maxit; I Denzler; D Marchione; G Agosta; J Koster; R J A Wanders; S Ferdinandusse; H R Waterham
Journal:  JIMD Rep       Date:  2016-08-25

Review 8.  Childhood cerebellar ataxia.

Authors:  Brent L Fogel
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

9.  Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios.

Authors:  Katharina Herzog; Mia L Pras-Raves; Martin A T Vervaart; Angela C M Luyf; Antoine H C van Kampen; Ronald J A Wanders; Hans R Waterham; Frédéric M Vaz
Journal:  J Lipid Res       Date:  2016-06-09       Impact factor: 5.922

10.  Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.

Authors:  Femke C C Klouwer; Sacha Ferdinandusse; Henk van Lenthe; Wim Kulik; Ronald J A Wanders; Bwee Tien Poll-The; Hans R Waterham; Frédéric M Vaz
Journal:  J Inherit Metab Dis       Date:  2017-07-04       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.